T HE androgen receptor (AR) belongs to the steroid and thyroid hormone receptor superfamily (1). It mediates the effects of testosterone and dihydrotestosterone on growth and differentiation of male urogenital organs (2). Factors that can modulate the expression of AR may play an integral role in these androgen-dependent processes (3).
It has been shown that several hormones and growth factors can regulate the expression of AR. In human cell lines and animal models, androgens can autoregulate the expression of AR (4, 5). For example, it has been shown that androgens decrease AR messenger RNA (mRNA) and protein levels in the rat prostate and several human cell lines (4-7). Conversely, it has been reported that AR mRNA and protein levels are increased by the administration of androgens in the rat and mouse prostate, as well as in human genital skin fibroblasts (g-10). More recently, Krongrad et al. (11) have shown that androgen down-regulation of AR mRNA is associated with a transient up-regulation of AR protein in LNCaP cells. It is not clear which intracellular mechanism mediates this autoregulation process, although transcriptional down-regulation of AR by androgens in LNCaP cells has been reported recently (12, 13) .
At least three distinct second messenger pathways exist within the cell: 1) the protein kinase A (PKA)-dependent pathway; 2) the PKC-dependent pathway; and 3) the calcium-calmodulin kinase-dependent pathway. All three pathways have been implicated in the regulation of the AR. For example, FSH, which activates the IX4 pathway, can stimulate the expression of AR mRNA and protein in the rat Sertoli cell (14) (characterization of the mouse AR and human AR (hAR) 5'-flanking regions indicated that sequences contained within the 5'-flanking region can mediate some of the effects of the PKA pathway on AR expression; 15, 16); epidermal growth factor, which activates the PKC pathway, can decrease AR mRNA levels in the human prostate cancer cell line LNCaP (17); and calcitonin, which alters Ca+' homeostasis, increases AR protein levels in rat Leydig cells (18).
The withdrawal of androgens from the prostate results in massive programmed cell death. It has been indicated that calcium ion influx into the cells may play a role in the pathway leading to androgen-induced apoptosis (19). Moreover, Martikainen and Issacs (20) has shown that in a rat ventral prostate organ culture system, an elevation of intracellular calcium in the presence of normal androgen levels could increase apoptosis to a similar level as caused by androgen ablation. Given these data, it seemed worthwhile to investigate whether increased intracellular calcium levels would affect AR mRNA and protein levels, and thereby affect the ability of androgens to control prostate function. the time points at which the cells were harvested for nuclei isolation for the transcription elongation reaction were 8 and 10 h after A23187 or thapsigargin was administered to the LNCaP cells. Hybridization was performed at 65 C for 72 h; washing of the blots was performed in 1 x SSC and 0.5% SDS at 55 C for 30 min. The film was exposed for 72 h.
Results
To determine whether intracellular levels of calcium affected the expression of the AR, the AR-containing cell line LNCaP was treated with the calcium ionophores A23187 (lo-" M) or ionomycin (lOeh M), or the intracellular Ca*+-ATPase inhibitor thapsigargin (lop7 M), for 16 h. RNA was analyzed on Northern blots incubated with an hAR cDNA probe. Three major AR mRNAs of 11, 8, and 4.7 kilobases were detected (Fig. 11 , which were of similar sizes to those reported previously for AR mRNA in LNCaP cells (27) . The expression of all three AR transcripts decreased after treatment with A23187, ionomycin, or thapsigargin.
The time dependencies of A23187 and thapsigargin downregulation of AR were examined next. Levels of AR transcripts in LNCaP cells began to decrease after 6-8 h of incubation with A23187 (lop6 M), reached a nadir after 16 h of incubation (29% of control), and increased to 59% of the control level at 24 h (Fig. 2) . Thapsigargin (lo-' M) treatment also resulted in a reduction in AR transcripts, decreasing after 6-8 h of incubation, reaching 23% of the control level after 10 h, and increasing to 68% of control by 24 h (Fig. 2) .
Next, the dose response of AR mRNA to A23187 and thapsigargin was examined. An 8-h treatment with thapsigargin reduced AR mRNA levels at doses as low as 50 nM, whereas higher concentrations of A23187 (about 500 nM) were required to reduce AR mRNA levels (Fig. 3) . These doses are similar to those reported previously for biological effects of these compounds (28). Next, AR protein levels were examined. As shown in thapsigargin effectively reduced AR protein levels after 12 h of incubation. However, at 24 h of incubation with either compound, the AR protein levels had almost returned to control levels. Calcium has been reported to induce apoptosis in prostate epithelial cells (19, 20) . To determine whether the observed effects on the AR were the result of apoptosis, LNCaP cells were incubated with different concentrations of A23187 or thapsigargin for various lengths of time (Fig. 5) . At the end of the experiments, no morphological differences were observed between control cells incubated with DMSO or cells treated with A23187 or thapsigargin (data not shown). Furthermore, A23187 had no effect on the growth rate of the LNCaP cells as measured by the MTT assay, indicating the viability of the cells. In the presence of thapsigargin, however, LNCaP cells became arrested in growth (Fig. 5) . The first morphological indications for apoptosis were observed after 36 h of culture in the presence of A23187 and 12 h later for thapsigargin (48 h; data not shown). These results suggest At the end of treatment, cells were incubated with 0.5 mg/ml M'l'l' for 4 h. Cells were lysed in DMSO, and 550 nm absorbance was measured by a multiwell plate reader. Viable cells at each dose are expressed as the percentage of control at that time (mean t SEM, n = 6; for thapsigargin the SEM was less than 3% and, consequently, could not be depicted in the graph). This experiment was repeated twice. that calcium-induced apoptosis is preceded by a downregulation of AR mRNA levels in LNCaP cells.
To explore the mechanism of calcium regulation of AR mRNA expression in LNCaP cells, we measured the effects of various inhibitors on the regulatory pathways in LNCaP cells. The dosages of these drugs and the time frames of the experiments were based on our previous experiences using endometrial carcinoma cell lines (29). The 30-min pretreatment of the cells with either cycloheximide, staurosporine, or trifluoperazine was performed to allow these compounds to exert their actions before intracellular calcium became increased. Cycloheximide was used to inhibit protein synthesis (30); staurosporine was used to inhibit PKC (31); and trifluoperazine was used to inhibit calmodulin (32). None of these inhibitors affected the AR mRNA levels, nor did they prevent the calcium down-regulation of AR mRNA levels (Fig. 6) . The lack of effect of staurosporine and trifluoperazine suggests that a pathway other than PKC or calmodulin might be involved.
Since cycloheximide had no effect, de ~ODO protein synthesis did not seem to be involved in the calcium effects on AR mRNA expression. Thus, the effect of calcium might be due to a posttranscriptional change in the half-life of the message. Therefore, we measured the effects of thapsigargin on AR mRNA half-life. LNCaP cells were incubated with DMSO or thapsigargin for 8 h and then treated with the RNA synthesis inhibitor actinomycin D (5 pg/ml) for different periods of time (O-24 h). As shown in Fig. 7 , the half-life of the AR mRNA in DMSO-treated LNCaP cells was 7.5 h. For thapsigargin-treated LNCaP cells, the half-life of AR mRNA was 8.1 h. This experiment showed that an accelerated turnover of AR mRNA in the presence of thapsigargin was not detectable in LNCaP cells, suggesting that a posttranscriptional mechanism of calcium down-regulation of AR mRNA in LNCaP cells was unlikely.
We next asked whether transcription of the AR gene was affected by A23187 or thapsigargin. Transcription of the AR gene in LNCaP cells, cultured in the presence of A23187 or thapsigargin, was measured using a nuclear run-on assay. As shown in Fig. 8 , transcription of both the AR gene and the AR GAPDH FIG. 6. Cycloheximide, staurosporine, and trifluoperazine effects on calcium ionophore A23187 and thapsigargin down-regulation of AR mRNA in LNCaP cells. LNCaP cells were treated with cycloheximide (10 @g/ml), staurosporine (lo-' M), or trifluoperazine (10m6 M) for 30 min before adding A23187 (10-s M) or thapsigargin (low7 M). Cells were incubated with A23187 or thapsigargin for 8 h. Total RNA was isolated and subjected to Northern blot analysis with bAR and GAPDH cDNA probes. This experiment was repeated twice. LNCaP cells were treated with lo-' M A23187 or 10e7 M thapsigargin for 8 or 10 h, respectively. Transcription elongation was allowed to continue for 30 min before total RNA was isolated from the nuclei of control and treated cells. The radioactively labeled RNAs were hybridized to: pBlue, background control vector; AR, mouse AR cDNA; and GAPDH, which serves to correct for variations in the loading of labeled RNA. This experiment was repeated twice.
GAPDH gene could be measured. However, no inhibition of AR gene transcription in LNCaP cells after 8 or 10 h of incubation in the presence of either A23187 or thapsigargin was observed, indicating that AR gene transcription is not affected by either A23187 or thapsigargin treatments. However, it is possible that the effects of both drugs on AR gene transcription were weak and consequently not detected using a nuclear run-on assay (12).
Discussion
The prostate is dependent on circulating concentrations of androgens and the presence of androgen receptors for normal growth, differentiation, and maintenance of differentiated functions (2,3). Thus, factors that regulate expression of the AR presumably regulate the ability of androgens to control prostate function. For example, it has been demonstrated that retinoic acid can down-regulate both AR protein levels and androgenic induction of prostate-specific androgen and hK2 mRNAs in LNCaP cells (33) .
The studies reported in this paper demonstrated that calcium can also modulate the expression of AR protein and mRNA in LNCaP cells. Thus, two distinct pathways, calcium and retinoic acid, are able to regulate AR expression and consequently androgen effects in the prostate.
In the current study two compounds, A23187 and thapsigargin, were used to increase intracellular calcium levels in LNCaP cells. A23187 is a Ca2+ ionophore, widely used to analyze the role of Ca2+ in the regulation of gene expression (3436). However, several disadvantages in the use of A23187 have been reported; A23187 has pleiotropic effects (34,36), and A23187 administration sometimes gives rise to a mixed Ca2+ and CAMP signal (35, 36) . Therefore, we also used the specific endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin. Its effects are reported to be highly specific by initiating only one event: a rapid increase in cytosolic free Ca2+. Thapsigargin has been reported to be a potent tumor promoter, inducing growth-and transformation-related genes in NIH3T3 cells (36). Its role in LNCaP cells, however, seems to be directly opposite of these observations, as will be described below.
Since calcium has been reported to mediate apoptosis in the rat ventral prostate (19, 20) , we tested the possibility of whether the down-regulation of AR by calcium could be due to the initiation of apoptosis. In our experiments, the calcium ionophore A23187 had no effect on cell growth or morphology, indicating that these cells were viable within the experimental setup. Thapsigargin treatment of the LNCaP cells, however, caused growth arrest. We do not think apoptosis is involved in thapsigargin-induced growth arrest, because the morphology of the cells remained unchanged during the 30-h incubation period (the first morphological changes were observed after 48 h; cells were rounding up and 24 h later were detaching from the plastic). Also, it has been demonstrated previously that cycloheximide can prevent calcium-induced apoptosis (37), suggesting that calciuminduced apoptosis of prostate cells requires new protein synthesis. However, in our studies, cycloheximide did not reverse the calcium effect on AR gene expression. Finally, expression of the housekeeping enzyme GAPDH was stable during treatment with either the calcium ionophore or thapsigargin. Our data suggest that the effect of calcium on AR mRNA occurs before apoptotic activation in LNCaP cells.
Several studies have shown that the calcium ionophore A23187 and thapsigargin can selectively activate gene expression (36,38) or inactivate gene expression via increasing intracellular calcium levels (28, 39, 40) . Recently, calciumactivated &-acting elements have been found in the 5'-flanking region of a glucose-and calcium-regulated grp78 gene (41, 42) . The sequence of this element is distinct from the CAMP response element, which mediates A23187 activation of the c-fos promoter (43), and from tetradecanoylphorbol acetate-and serum-responsive elements that have been shown to mediate thapsigargin activation of the c-jun and c-fos promoters (36). Interestingly, sequences within the hAR 5'-flanking region show strong homology to the A23178-induced elements of thegrp78 gene. Although nuclear run-on experiments showed no effect on the regulation of AR gene transcription by A23187 or thapsigargin treatment, it is possible that this assay is not sensitive enough to pick up relatively small differences in the gene transcription rate (12); therefore, transcriptional regulation of AR mRNA cannot be ruled out.
Calcium effects on gene expression are usually dependent on a rapid phosphorylation mechanism mediated by calmodulin or other calcium-regulated kinases. Calcium normally induces rapid expression of many genes such as c-jun and c-fos. However, inhibition of gene expression by calcium usually occurs with a pattern of relatively slow kinetics (39, 41) . Calcium inhibition of the AR gene occurred after 6 h of incubation with A23187 and thapsigargin. This would argue against fruns-activation of AR via a rapid phosphorylation mechanism. The inability of staurosporine, a PKC inhibitor (311, and trifluoperazine, a calmodulin inhibitor (32), to reverse the calcium inhibition of AR gene expression also supports the argument that calcium down-regulation of AR gene expression occurs by a mechanism other than phosphorylation.
In conclusion, increases in intracellular calcium concentration by the calcium ionophore or thapsigargin effectively reduce AR expression in LNCaP cells. Calcium inhibition of AR expression seems to precede calcium-induced apoptotic cell death. Furthermore, the mechanism of this reduction seems to be different from a pathway in which the calcium signal is transduced via a phosphorylation mechanism. 41.
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